| Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
1 |
| Advanced and Metastatic Breast Cancer |
0 |
0.8 |
| Breast |
0 |
0.64 |
| Antineoplastic Drug |
0 |
0.61 |
| Targeted Cancer Therapy |
0 |
0.61 |
| Cancer |
0 |
0.6 |
| Toxicology |
0 |
0.45 |
| Genomic Medicine |
0 |
0.42 |
| Tumor |
0 |
0.3 |
| Humanized Monoclonal Antibody |
0 |
0.19 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Clinical Research |
0 |
0.15 |
| Hodgkin Lymphoma |
0 |
0.12 |
| Antibody Drug Conjugates |
0 |
0.11 |
| Chemotherapy |
0 |
0.11 |
| Interstitial Lung Disease |
0 |
0.11 |
| Lung |
0 |
0.11 |
| Epidermal Growth Factor Receptor |
0 |
0.08 |
| Receptors |
0 |
0.07 |
| Immunotherapy |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Wound Management |
0 |
0.04 |